The Unmasking of Telomerase  by Legassie, Jason D. & Jarstfer, Michael B.
Structure 14, 1603–1609, November 2006 ª2006 Elsevier Ltd All rights reserved DOI 10.1016/j.str.2006.09.004MinireviewThe Unmasking of TelomeraseJason D. Legassie1 and Michael B. Jarstfer1,*
1Division of Medicinal Chemistry and Natural Products
School of Pharmacy
University of North Carolina
Chapel Hill, North Carolina 27599
Telomerase is a ribonucleoprotein complex that re-
verse transcribes a portion of its RNA subunit during
the synthesis of G-rich DNA at the 30 end of each chro-
mosome in most eukaryotes. This activity compen-
sates for the inability of the normal DNA replication
machinery to fully replicate chromosome termini.
The roles of telomerase in cellular immortality and tu-
mor biology have catalyzed a significant interest in
this unusual polymerase. Recently the first structures
of two domains, the CR4/CR5 and pseudoknot, of hu-
man telomerase RNA (hTR) were reported, offering
a structural basis for interpreting biochemical studies
and possible roles of hTR mutations in human dis-
eases. Structures of the stem II and stem IV domains
of Tetrahymena thermophila TR as well as the N-termi-
nal domain of the T. thermophila telomerase reverse
transcriptase have also been determined. These stud-
ies complement previous biochemical studies, provid-
ing rich insight into the structural basis for telomerase
activity.
The end-replication problem is the inherent inability of
primer-based DNA replication to fully replicate linear
DNA molecules (Olovnikov, 1973; Watson, 1972). Nature
has evolved several solutions to the end-replication
problem (Nosek et al., 2006), but the vast majority of
all eukaryotes use the enzyme telomerase to ensure
that the chromosome ends are completely replicated
(Smogorzewska and de Lange, 2004). Telomerase has
generated a significant level of attention because of its
connection to cellular mortality. Telomere length, which
is regulated by telomerase activity, regulates replicative
aging, possibly as a mechanism to oppose the prolifer-
ation of cancer cells. In humans, telomerase activity is
low or undetectable in somatic cells but is upregulated
in the majority (w90%) of cancer cells (Shay and Bac-
chetti, 1997).
Telomerase activity was first identified in the ciliate
Tetrahymena thermophila by Greider and Blackburn
(1985). Based on the observed sensitivity to ribonucle-
ase A, they determined that telomerase was an RNA-de-
pendent enzyme. After the single RNA subunit was iden-
tified, mutagenesis studies confirmed that it harbored
the telomerase template (Yu et al., 1990), establishing
telomerase as a ribonucleoprotein complex that reverse
transcribes a small portion of its integral RNA subunit.
Since this seminal work, telomerase activity has been
observed in a wide variety of eukaryotes, and its primary
constituent parts have been identified (Autexier and Lue,
2006; Harrington, 2003).
*Correspondence: jarstfer@unc.eduAfter first being discovered from T. thermophila, telo-
merase RNA (TR) was identified in several ciliates, yeast,
and vertebrates (Theimer and Feigon, 2006). In each, the
template, which is complementary to the telomeric DNA
sequence, represented only a small portion of the total
RNA sequence, foreshadowing a greater role for the
RNA subunit in telomerase biochemistry. The telome-
rase protein subunits resisted identification until Lingner
and Cech (1996) purified telomerase from the ciliate Eu-
plotes aediculatus, and peptide sequences were ob-
tained by the Mann laboratory (Lingner et al., 1997).
Two proteins were identified: p43 and p123. Concomi-
tantly, the Lundblad lab identified several genes from
a yeast genetic screen for an est (ever shorter telomeres)
phenotype (Lendvay et al., 1996). One of the gene prod-
ucts, Est2p, was homologous to p123, and both con-
tained amino acid sequences that are hallmarks of re-
verse transcriptases (RT). Mutation of the conserved
RT motifs in Est2p resulted in an est phenotype, con-
firming the identification of the telomerase catalytic sub-
unit (Lingner et al., 1997), which is commonly referred to
as telomerase reverse transcriptase (TERT) (Nakamura
and Cech, 1998). This seminal work ushered in a new
phase in telomerase biochemistry, as it allowed the
identification of TERT homologs in a wide variety of
organisms.
While TR and TERT are the minimal requirements for
telomerase activity in vitro, additional components of
the telomerase holoenzyme are required in vivo and
have been identified by various approaches. When telo-
merase was purified from E. aediculatus, a homolog of
the human La protein, p43, was identified (Lingner and
Cech, 1996). Subsequently, the human La protein was
found to coimmunoprecipitate with telomerase from hu-
man cells (Ford et al., 2001). In E. aediculatus, p43 is in-
volved in nuclear retention of the telomerase complex
(Mollenbeck et al., 2003) and its T. thermophila ortholog
p65 is involved in telomerase assemblage (O’Connor
and Collins, 2006). The yeast genetic screen for the
EST mutants identified several other proteins besides
Est2p, the yeast TERT (Lendvay et al., 1996). Two of
these proteins, Est1p and Est3p, are demonstrably
part of the yeast telomerase complex (Hughes et al.,
2000; Lin and Zakian, 1995), and yeast Est1p regulates
telomerase (Evans and Lundblad, 2002; Osterhage
et al., 2006). Est1p appears to be a common telomerase
subunit, as homologs have been identified in human
(Reichenbach et al., 2003; Snow et al., 2003) and fission
yeast (Beernink et al., 2003). Several other proteins have
been identified as telomerase components, and the tel-
omerase holoenzyme is the subject of other recent re-
views (Autexier and Lue, 2006; Harrington, 2003).
This review discusses recent progress toward under-
standing the relation of the structure of telomerase to its
function. The biochemical activities of telomerase have
received substantial attention (Autexier and Lue, 2006;
Harrington, 2003; Kelleher et al., 2002). Therefore, the fo-
cus here will be on the solution structures of catalytically
and structurally essential regions of human (Leeper
et al., 2003; Leeper and Varani, 2005; Theimer et al.,
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1604Figure 1. Secondary Structure of Telomerase RNAs
Elements common between at least two of the RNAs are highlighted by color as described in the legend. Dark gray brackets and text illustrate
regions defined to interact with a specific protein. The putative Saccharomyces TR pseudoknot is depicted as two conserved stem-loops with
a connector linking the possible pseudoknot-forming interaction. The light gray regions of yeast TR are dispensable for forming an active telo-
merase particle in vivo and in vitro as determined by Zappulla et al. (2005). The yeast TR nomenclature is as previously reported (Dandjinou et al.,
2004; Lin et al., 2004; Zappulla and Cech, 2004).2005) and T. thermophila telomerase RNA (Chen et al.,
2006; Richards et al., 2006a) and the first crystal struc-
ture of the N-terminal domain of TERT (Jacobs et al.,
2006). Given the current level of interest in telomerase,
these studies represent significant advances for the field
and portend future progress in telomerase biochemistry
and rational drug design targeting the human telome-
rase complex.
Telomerase RNA
TRs from diverse species differ greatly in their size and
share little sequence homology, but do appear to share
common secondary structures (Figure 1). Important
common features include a template, a 50 template
boundary element, a large loop including the template
and putative pseudoknot, and a loop-closing helix. The
ciliate (Romero and Blackburn, 1991), vertebrate (Chen
et al., 2000, 2002), and yeast (Dandjinou et al., 2004;
Lin et al., 2004; Zappulla and Cech, 2004) TR structures
have been established by comparative phylogenetic
and mutational analyses. Interestingly, the core struc-
ture of the large, 1157 nt, yeast TR can be reduced toa functional w500 nt RNA (Zappulla et al., 2005). Re-
cently, NMR spectroscopy has confirmed the proposed
structures of several domains from ciliate and human TR
(Chen et al., 2006; Leeper et al., 2003; Leeper and Varani,
2005; Richards et al., 2006a, 2006b; Theimer et al., 2005).
The Structure of Tetrahymena thermophila
Telomerase RNA
The structures of two T. thermophila TR domains, stem-
loop II of the template boundary element (Richards et al.,
2006a) and the transactivating domain stem-loop IV
(Chen et al., 2006; Richards et al., 2006b), were deter-
mined by NMR spectroscopy (Figure 2). The structure
of stem-loop II is significant because its template prox-
imal portion, specifically base pair G37$C19, is essential
for proper template boundary definition. Stem-loop II
forms a tight 7 nt long A-form helix containing six base
pairs and one pair of opposing, un-base-paired ade-
nines that stack into the middle of the helix. The penta-
loop is well defined, with A29 in a rare syn conformation.
Surprisingly, the distal portion of stem-loop II appears to
be dispensable for activity and TERT binding (Lai et al.,
Minireview
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the entire stem-loop II is a necessary motif. Instead, it
may function to facilitate high-affinity TERT binding by
bringing together the two flanking template boundary el-
ements present 30 and 50 of stem II, sequences 50-UCA
and 50-CAUU, respectively (Lai et al., 2002; Licht and
Collins, 1999). The absolute identity of these nucleotides
as well as their location two residues 50 of the template is
required for tTERT binding (O’Connor and Collins, 2006)
and for enzymatic activity (Autexier and Greider, 1995;
Lai et al., 2002; Licht and Collins, 1999). This proposal
is supported by the fact that T. paravorax contains these
template boundary elements in close proximity, but
lacks stem-loop II (McCormick-Graham and Romero,
1995).
More recently, the solution structure of the 43 nt stem-
loop IV domain from T. thermophila TR was reported
(Chen et al., 2006; Richards et al., 2006b). Stem-loop
IV has been implicated in TERT binding (Lai et al.,
2003), proper pseudoknot folding (Sperger and Cech,
2001), and processivity (Mason et al., 2003), and the
proximal portion of stem-loop IV has recently been iden-
tified as a p65 binding site (Prathapam et al., 2005).
Stem-loop IV forms a severely kinked structure capped
by a structured 7 nt loop that is closed by a noncanonical
C$U base pair (Figure 2). The eight base-pair helix pre-
ceding the apical loop is interrupted by a bulged U,
which is identified as U127 in one population of struc-
Figure 2. Solution Structures of T. thermophila Telomerase RNA
Domains
The sequences for stem-loop II and IV are shown next to the atomic
coordinates with the conserved template boundary element in stem
II colored black. Nucleotides are colored as follows: canonical base
pairs (cyan), loops (magenta), and nucleotides in unique configura-
tions are colored as follows: A22, A29, A34, A122 (red), C19, C132
(blue), U117, U127, U138 (orange), and G37, G121 (green). The tem-
plate is colored blue. The kink formed by the GA bulge in stem-loop
IV is highlighted by dotted black lines. The GA121–122 bulge in
stem-loop IV and the G37$C19 base pair in stem-loop II are draw
as spheres to highlight their location. Coordinates for all structures
were rendered using PyMOL (http://www.pymol.org).tures and U126 in another population, suggesting that
this region is in conformational flux. The unpaired GA
bulge in the center of stem-loop IV severely kinks the
structure by 40–50, confirming previous predictions
(Bhattacharyya and Blackburn, 1994). Deleting the GA
bulge, but not mutating its sequence, prevents reconsti-
tution of telomerase activity, consistent with the pro-
posal that stem-loop IV must be kinked for proper telo-
merase function (Sperger and Cech, 2001). Because
stem IV can be added in trans, it seems that the GA-
induced kink allows proper positioning of the distal
stem-loop within the telomerase complex (Mason
et al., 2003; Richards et al., 2006b).
Even though these NMR studies were conducted with
isolated domains of tTR, they are pertinent because the
features of the structures are consistent with chemical
and enzymatic probing of full-length tTR in solution
and in the telomerase complex (Bhattacharyya and
Blackburn, 1994; Chen et al., 2006; Sperger and Cech,
2001; Zaug and Cech, 1995).
The Structure of Human Telomerase RNA
Human telomerase activity can be reconstituted by add-
ing both the pseudoknot (nt 1–209) and the CR4/CR5 (nt
241–330) domains to hTERT in vitro and thus are the only
TR domains required for catalytic activity (Tesmer et al.,
1999). Furthermore, these domains bind independently
to mammalian TERTs (Chen and Greider, 2003; Keppler
and Jarstfer, 2004). Accordingly, they have been the fo-
cus of several structural studies, and the separate ef-
forts of the Feigon and Varani groups have led to solu-
tion structures of portions of these domains (Leeper
et al., 2003; Leeper and Varani, 2005; Theimer et al.,
2005) (Figure 3).
The CR4/CR5 domain, including the p6a and p6b he-
lices with an interconnecting loop (Leeper and Varani,
2005) and the essential p6.1 hairpin (Leeper et al.,
2003), was reported by the Varani lab. The 32 nt struc-
ture of the p6a/J6/p6b hairpin contained 20 nt of the na-
tive sequence and evinces several important structural
features of the human TR (Figure 3). Although phyloge-
netic analysis could not confirm base pairing in this re-
gion, the NMR-based model clearly shows a stable sec-
ondary structure with the two pairing regions, p6a and
p6b, in standard A-form helices, consistent with foot-
printing data (Antal et al., 2002). The two helices are per-
turbed 20 from a coaxial alignment by loop J6. Though
the role of J6 has not been extensively probed, it is a con-
served element in all mammalian TRs (Chen et al., 2000)
and the solution structure reveals a solvent-accessible
tunnel. Interestingly, N3 of C290, which forms one wall
of this tunnel, is protected from dimethyl sulfoxide in
vivo (Antal et al., 2002) but not in vitro, suggesting that
this tunnel is a receptor for hTERT or another compo-
nent of the telomerase holoenzyme.
The p6.1 hairpin was first identified as an essential
secondary structure of mammalian TRs by mutational
analysis demonstrating the requirement of the stem re-
gion and two conserved residues, U307 and G309,
(Chen et al., 2000, 2002). Subsequently, a role of the hu-
man p6.1 hairpin in binding hTERT and in enzymatic ac-
tivity was established (Moriarty et al., 2004). The solution
structure of the p6.1 hairpin contains four canonical
base pairs in the helix capped by a wobble base pair
U306$G310 (Figure 3). The p6.1 loop contains three
Structure
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merase RNA Domains
Black dashed lines indicate the location of
the individual structures in the full-length
RNA. The full-length RNA and sequence of
the individual structure elements are colored
to match the ribbon diagrams. For the pseu-
doknot, the p2b helix is cyan, the p3 helix is
green, the J2a/3 loop is blue, the J2b/3 loop
is pink, and U177, which was deleted in the
construct used for structure determination,
is black. For the CR4/CR5 domain, the p6a
helix is cyan, the J6 bulge is green, the p6b
helix is pink, the p6.1 helix is cyan, uridines
in the loop are orange, and guanosines in
the loop are green. Residues in the NMR
structures that are not native to human TR
are colored gray.nucleotides that present their Watson-Crick faces to the
solvent. This solvent exposure is recapitulated by foot-
printing of full-length hTR, but these same residues are
protected in vivo (Antal et al., 2002). Thus, these resi-
dues may be directly involved in protein interactions
(Moriarty et al., 2004) or long-range interactions with
the telomerase template (Ueda and Roberts, 2004).
The highly conserved pseudoknot domain of verte-
brate TRs has been extensively investigated, owing to
its predicted roles in telomerase functions and because
mutations of this region of human TR are associated with
several diseases (Chen and Greider, 2004; Theimer and
Feigon, 2006). Recent solution structures of RNAs repre-
senting portions of the pseudoknot domain have greatly
illuminated previous work and will continue to guide fu-
ture efforts toward understanding the role of TR in telo-
merase function (Theimer et al., 2003a, 2003b, 2005).
The structure of the human pseudoknot contains helices
p2b and p3 and loops j2b/3 and j2a/3 including nt 93–121
and nt 166–174, with U177 deleted for stability reasons.
These represent all of the residues required for forma-
tion of the conserved H-type pseudoknot (Theimer
et al., 2005). The pseudoknot forms a well-ordered struc-
ture with the U-rich j2b/3 loop (U99–U106) residing in the
major groove of helix p3 and the A-rich j2a/3 loop (C166–
A173) located in the minor groove of helix p2b. Nucleo-
tides U99–U101 of the j2b/3 loop form three U$A$U
base triplets with the first three base pairs in helix p3,
while A171 and A173 of the j2a/3 loop form two nonca-
nonical base triplets. Each of these tertiary interactions
was validated by mutational and thermodynamic studies
on the stability of the pseudoknot. Importantly, telome-rase activity correlated with the relative stability of these
pseudoknot mutants (Theimer et al., 2005).
The formation of the pseudoknot in full-length human
TR and within cells is not supported by chemical and en-
zymatic footprinting (Antal et al., 2002). This could be ex-
plained if the pseudoknot exists in an alternative, par-
tially unfolded p2b hairpin that is in equilibrium with
the pseudoknot structure, as previously proposed (Co-
molli et al., 2002; Theimer et al., 2003b). The structure
of the p2b hairpin contains a unique series of polypyrimi-
dine base pairs including three U$U base pairs and a
water-mediated U$C base pair capped by a structured
pentaloop (Theimer et al., 2003b). Interestingly, the dys-
keratosis congenita-associated mutation GC(107-8)AG
was found to stabilize the p2b hairpin and destabilize
the pseudoknot conformation. Structurally, the basis
for the increased stabilization is owed to a stabilizing
YNMG-like tetraloop structure (Theimer et al., 2003a).
Telomerase Reverse Transcriptase
The catalytic subunit of telomerase, TERT, has been
identified from several organisms and analysis of their
sequences reveals a conserved primary structure that
can be broken up into at least four domains (Autexier
and Lue, 2006; Kelleher et al., 2002). A centrally located
RT domain contains all seven of the universally
conserved RT motifs, mutation of which disrupts telome-
rase activity. A high-affinity RNA-binding domain N-ter-
minal of the RT motifs, the N-terminal proximal domain
known as RID2, has been confirmed in both hTERT and
tTERT (Bachand and Autexier, 2001; Bryan et al., 2000;
O’Connor et al., 2005). A second N-terminal domain, dis-
tal to the RT motifs and referred to as RID1, TEN, or DAT,
Minireview
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Moriarty et al., 2005), and mutations of hTERT within
this domain separate in vivo function from catalytic activ-
ity (Armbruster et al., 2001). The fourth domain is the C-
terminal domain, which is essential for hTERT and tTERT
(Autexier and Lue, 2006) and has been implicated in pro-
moting processive polymerization (Huard et al., 2003).
This domain is absent in round worms, suggesting that
its functions have been supplanted by other domains
within TERT or other subunits of the telomerase complex
in these organisms (Malik et al., 2000; Meier et al., 2006).
Recently, a high-throughput screen was conducted to
identify domains of T. thermophila TERT that can be ex-
pressed in soluble form in Escherichia coli (Jacobs et al.,
2005). The screen successfully identified a 23.5 kDa frag-
ment representing residues 2–191, which encompasses
the TERT essential N-terminal distal domain, TEN. Sub-
sequently, Jacobs et al. (2006) crystallized this portion of
tTERT to generate the first high-resolution structure of
a domain from the catalytic subunit of telomerase (Fig-
ure 4). The structure of the TEN domain represents
a unique protein fold and contains several residues
that are conserved among all TERT sequences identified
save TERT from round worms, which share only weak
homology in the TEN domain (Meier et al., 2006). In
TEN-containing TERTs, the invariant glycine residues
G144 and G171 (T. thermophila numbering) seem to be
involved in proper folding as they connect two different
secondary structure elements via sharp turns. An impor-
tant feature of the TEN structure constitutes a deep
groove that runs from the C terminus to the center of
the structure and is composed of several conserved res-
idues that are important for catalytic activity, and the
floor of this groove contains the invariant residue Q168.
The TEN domain has been implicated in DNA and RNA
binding. However, the isolated domain only weakly
binds single-stranded telomeric DNA. Photo-crosslink-
ing was therefore used to demonstrate sequence-spe-
cific binding of TEN to telomeric DNA. Importantly, mu-
tants Q168A, F178A, and W187A all abrogated crosslink
formation to the TEN domain and greatly reduced telo-
merase activity in the context of full-length TERT. Be-
cause these residues reside near each other in the
deep groove found in the TEN domain, it is tempting to
speculate that this groove is involved in binding to and
aligning the telomere into the telomerase active site
and may be the anchor site that other studies have impli-
cated (Hammond et al., 1997; Lue, 2005; Moriarty et al.,
2005). The role of the TEN domain in affinity and specific-
ity of telomere binding is further suggested by mutations
within the N-terminal domain of hTERT that affect elon-
gation of telomeric but not nontelomeric DNA primers
(Armbruster et al., 2001; Lee et al., 2003), mutations in
the TEN domain of hTERT that are rescued by increasing
primer concentration (Moriarty et al., 2005), and deletion
mutants of yeast TERT that affect elongation of primers
forming only short duplexes with the telomerase tem-
plate (Lue, 2005).
Telomerase Holoenzyme and Telomerase Subunits
The telomerase holoenzyme minimally contains TR and
TERT. However, several other subunits are known to be
a part of the telomerase holoenzyme and these have re-
cently been reviewed (Autexier and Lue, 2006; Harring-
ton, 2003). Most of these proteins were identified bycopurification, and many have been confirmed as telo-
merase components by exhibiting a telomere mainte-
nance phenotype when mutated. Currently, the struc-
tural basis for holoenzyme assemblage is poorly
understood, but we can expect further elucidation of
the telomerase complex structure and confirmation of
its subunits to follow. One approach that has been par-
ticularly productive in this regard is the use of an endog-
enously expressed, epitope-tagged TERT to facilitate
tandem affinity purification of telomerase subunits in T.
thermophila. In this way, the Collins laboratory identified
four new subunits, two of which, p45 and p65, were
required for telomere maintenance in vivo (Witkin and
Collins, 2004).
One of the major structural questions regarding the
telomerase holoenzyme is the oligomerization state of
the complex. Biochemical data suggest that the human
(Wenz et al., 2001) and yeast (Prescott and Blackburn,
1997) telomerase complexes exist in dimeric forms,
whereas telomerase from E. crassus (Wang et al.,
2002) can exist in both dimeric and higher order forms
depending on the life-cycle stage of the organism. Inter-
estingly, telomerase from T. thermophila exists as
a monomer, suggesting that the inherent biochemical
activity of telomerase does not require a dimeric com-
plex (Bryan et al., 2003). Recently, direct evidence for
the oligomerization state of E. aediculatus telomerase
was provided by electron microscopy (Fouche et al.,
2006). In this experiment, E. aediculatus telomerase
was visualized at the ends of synthetic chromosomes
as a dimer, with two types of structures primarily ob-
served: single DNA molecules with a telomerase dimer
at one end and two DNA molecules brought together
by two telomerase dimers.
Conclusion
The importance of telomerase to stem-cell technology,
anticancer therapies, and human disease ensures that
the initial structures of this fascinating enzyme are only
a beginning. As the field expands, we can anticipate
the ability to address several important questions re-
garding the mechanism of telomerase. Foremost, what
is the structural basis for template identification and
accurate template utilization and related questions re-
garding orchestration of processive primer elongation
and promotion of telomere association, given the limited
base pairing between the template and telomere?
Increasing knowledge of the structure of human telo-
merase will facilitate rational drug design. Currently,
Figure 4. Crystal Structure of the Essential N-Terminal Domain of
TERT from T. thermophila
(A) Ribbon diagram of the TEN domain with helices in cyan, sheets in
purple, and loops in orange. Residues implicated in binding to the
telomeric primer are highlighted in red. Conserved glycines are high-
lighted in yellow.
(B) Surface representation of the TEN domain is highlighted as in (A).
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1608small-molecule telomerase inhibitors are being identi-
fied by random screening followed by optimization
through chemical modification. While this has identified
several potent molecules, the affinities of most are not
high enough to warrant advancement into the clinic,
even though an oligonucleotide-based template antag-
onist has entered clinical trials (Djojosubroto et al.,
2005). Given the success of virtual screening to enhance
the rational design of small-molecule ligands, it is clear
that the field of telomerase-targeted therapeutics will
rapidly expand as the structural biology of telomerase
is advanced.
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